Subject: RE: FF-up on Immunization and family planning exp. that were missing in your accounts
From: "David Gzirishvili (CGC)" <[email-masked]>
To: Ketevan Goginashvili <[email-masked]>
Date: Tue, 28 Jan 2020 11:19:28 +0000

საკვირველი... ანუ სანამ კონსულტანი იყო ტრინი, მერე რა, და რაკი ჯმო-ს თანამშრომელი გახდა... კაი, არ აქვს მნიშვნელობა.

მნიშვნელობა იმას აქვს ჩემთვის, რომ თებერვალში არ ვიქნებით მზად (მონაცემებს ვგულისხმობ). გადაიწევს ყველაფერი სულ მცირე 2 თვით (თებერვალი მქონდა გამონთავისუფლებული, და ახლა უნდა „ჩავაკვეხო“ სადმე....).

David Gzirishvili

Managing Partner

Consulting Group Curatio Sarl

Geneva, Switzerland

From: Ketevan Goginashvili

Sent: Tuesday, January 28, 2020 12:11

To: David Gzirishvili (CGC)

Subject: RE: FF-up on Immunization and family planning exp. that were missing in your accounts

ოოო პირდაპირი, მის დასახვედრად ყველაფერი გავიარეთ ბარსელონის ოფისთან რაც გვაკავშირებს და ყველა ვალდებულებებიიი, მათ შორის ჯანდაცვის ანგარიშები
და ასე გადაება...

From: David Gzirishvili (CGC) [mailto:[email-masked]]

Sent: 28 January, 2020 15:07

To: Ketevan Goginashvili

Subject: RE: FF-up on Immunization and family planning exp. that were missing in your accounts

ქეთი
გმადლობ
ოპერატიულად
პასუხის
გაცემისთვის!
😊

გინდა
მიწერე
და
გადაუგზავნე
2016 პირდაირ
Natalja Eigo-ს,
ან
მომეცი
მე
და
მივცემ.

Trin
რომ
მაქაა
ვიცი,
შეიძლება
შევხდე
ხუთშაბათს,
რომ
დავბრუნდები.

ერთი
ვერ
გავიგე:
ტრინი
და
ჩვენი
საჭიროებისთვის
მონაცემების
გამოთხოვა (ანუ
შენთვის
ამ
უფლებამოსილების
მინიჭება)
ერმთანეთთან
რა
კავშირშია?

David Gzirishvili

Managing Partner

Consulting Group Curatio Sarl

Geneva, Switzerland

From: Ketevan Goginashvili <[email-masked]>

Sent: Tuesday, January 28, 2020 11:48

To: David Gzirishvili (CGC) <[email-masked]>

Subject: RE: FF-up on Immunization and family planning exp. that were missing in your accounts

დათო მოგესალმები,

დღეს ტრინი იყო აქ. ამას  შედეგად მოყვა, რომ ინფორმაციის გამოთხოვის ნებართვა მაქვს და ახლა ვუშვებ ყველგან ოფიციალურ წერილებს.

2016, 2017 ჯანდაცვის ანგარიშები გვაქვს და იმუნიზაციის ხარჯების გამოყოფაც არის შესაძლებელი...

პატივისცემით, ქეთი

From: David Gzirishvili (CGC) [mailto:[email-masked]]

Sent: 28 January, 2020 14:36

To: Ketevan Goginashvili

Subject: FW: FF-up on Immunization and family planning exp. that were missing in your accounts

ქეთი,
გაუმარჯოს!

არის
რაიმე
წინსვლა
ჩვენს
ფრონტზე?
ხელმძღვანელობა
გააქტიურდა
მონაცემების
მოსაპოვებლად?
თუ
კორონაროვირუსის
აჩრდილმა
გადაფარა
ყველაფერი?
😊

ნატალია
ჟენავაში
ისევ
გააქტიურდა
და
მთხოვს,
თუ
გვაქვს
HC.6.2 (იმუნიზაცია)
ხარჯები (შიდა
და
გარე
წყაროებიდან) 2016
წლის.
მე
ვუთხარი,
რომ 2016
წლის
HA მგონი
არ
არის
დათვლილი.
სწორად
ვუთხარი?

დამაკვალიანე
რა...
😊

David Gzirishvili

Managing Partner

Consulting Group Curatio Sarl

Geneva, Switzerland

From: David Gzirishvili (CGC)

Sent: Tuesday, January 28, 2020 11:34

To: EIGO, Natalja <[email-masked]>

Cc: XU, Ke <[email-masked]>; TOURE, Hapsatou <[email-masked]>; Baktygul Akkazieva (WHO) <[email-masked]>

Subject: RE: FF-up on Immunization and family planning exp. that were missing in your accounts

Dear Natalja,

I just recalled the country said they had not produced HA for 2016.

Nevertheless, I will contact the focal point in Georgia.

I can further follow it up after I return in Tbilisi (on Thursday) if it is not too late.

All the best,

David Gzirishvili

Managing Partner

Consulting Group Curatio Sarl

Geneva, Switzerland

From: EIGO, Natalja <[email-masked]>

Sent: Tuesday, January 28, 2020 11:22

To: David Gzirishvili (CGC) <[email-masked]>

Cc: XU, Ke <[email-masked]>; TOURE, Hapsatou <[email-masked]>; Baktygul Akkazieva (WHO) <[email-masked]>

Subject: RE: FF-up on Immunization and family planning exp. that were missing in your accounts

Dear David,

Thank you for your prompt response.

Yes, you are right about TJK. Thank you for sharing the data once again.

For Georgia, yes, could you kindly ask the country to share data for 2016 with us? Could you also ask what they think what share of immunization is included in HC63 (by SHA1.0)? In this case
we will have HC62 by SHA2011.

Thanks a lot,

Natalja

From: David Gzirishvili (CGC) <[email-masked]>

Sent: Tuesday, January 28, 2020 9:30 AM

To: EIGO, Natalja <[email-masked]>

Cc: XU, Ke <[email-masked]>; TOURE, Hapsatou <[email-masked]>; AKKAZIEVA, Baktygul <[email-masked]>

Subject: RE: FF-up on Immunization and family planning exp. that were missing in your accounts

Dear Natalja,

Please see my responses below in your email.

All the best,

David Gzirishvili

Managing Partner

Consulting Group Curatio Sarl

Geneva, Switzerland

From: EIGO, Natalja <[email-masked]>

Sent: Tuesday, January 28, 2020 09:10

To: David Gzirishvili (CGC) <[email-masked]>

Cc: XU, Ke <[email-masked]>; TOURE, Hapsatou <[email-masked]>; Baktygul Akkazieva (WHO) <[email-masked]>

Subject: RE: FF-up on Immunization and family planning exp. that were missing in your accounts

Dear David,

Thank you for the data. Following up our discussion on Friday we has to publish immunization
HC62 x FS ( gghed, external, private and total)
data for years 2016-2017 in June 2020.

Gavi countries on your list are the following:
Georgia, KRG, Moldova and Tajikistan.

Could you kindly provide the following data ASAP:

·
For Tajikistan we need HC62 by external sources for 2016 year. It is only HC62xgghed presented for now. We really need external funds as well.[DGz] I thought the folder with HAPT reports for 2014-2017 I shared contains
everything you needed about HC62. Just in case, I attached 2016 and highlighted HC62 in HC x HF and HC x FS tables

·
For Moldova we need HC62 x FS(gghed, external) if possible private and total as well) for both years 2016 and 2017. This cross-classification is missing in the table sent by you.[DGz] I am sorry MDA computation of HA 2017 is
not up to the standards. But as I tried to explain we have little leverage in how the country produces HA and in the quality and completeness of the computations. I shared the file as received from the country after all deadlines had passed.

·
I understand that Georgia uses SHA 1.0 yet. It is ok. We will do our estimations, but we need data for 2016 by HC and HF (public, external and private)[DGz] I am sorry but we have not been involved in the HA production before
2017. What I can do is to contact the country focal point and ask her to share the HA 2016 file (I don’t know even if it exists) directly with you. Would it be fine with you?

Thank you very much!

Natalja

From: David Gzirishvili (CGC) <[email-masked]>

Sent: Friday, January 24, 2020 3:52 PM

To: EIGO, Natalja <[email-masked]>

Cc: XU, Ke <[email-masked]>; TOURE, Hapsatou <[email-masked]>; AKKAZIEVA, Baktygul <[email-masked]>

Subject: RE: FF-up on Immunization and family planning exp. that were missing in your accounts

Dear Natalja and Ke,

It was so nice to savour morning coffee and discussion with you today
😊.

Family planning

I checked KGZ – you have four lines under DIS.2, including DIS.2.3
😊. The previous year reports are in the folder I shared previously.

HC x HF or HC x FS

Macedonia 2017 – attached. The highest level of granulation and credibility of all classification.

Belarus – you can

download their HA 2018 excel file or enjoy  HC x HF cross-tab I extracted and attached. Sorry, it uses SHA 1.0

Georgia – attached. Sorry… it still uses SHA 1.0

Kazakhstan – attached. Cannot comment on its credibility.

Moldova – Attached HA 2017 excel as received from the focal point. We cannot comment on its quality.

All the best,

David Gzirishvili

Managing Partner

Consulting Group Curatio Sarl

Geneva, Switzerland

From: EIGO, Natalja <[email-masked]>

Sent: Friday, January 24, 2020 14:44

To: David Gzirishvili (CGC) <[email-masked]>

Cc: XU, Ke <[email-masked]>; TOURE, Hapsatou <[email-masked]>

Subject: RE: FF-up on Immunization and family planning exp. that were missing in your accounts

Dear David,

It was a pleasure to meet you today.

Just as a reminder for all of us that today we agreed that you will send us HC data (if possible crossed with FS or HF) for 2017 year for following countries: Georgia, Belarus, Moldova, Kazakhstan
and Macedonia.

Also please check DIS23 x gghed for KRG. We really need this data.

We will see what happened on Monday if we will have a  meeting with our vendor and have questions about HAPT.

In this case I will try to connect you.

Have a nice weekend,

Natalja

From: David Gzirishvili (CGC) <[email-masked]>

Sent: Thursday, January 23, 2020 2:39 PM

To: EIGO, Natalja <[email-masked]>

Cc: XU, Ke <[email-masked]>

Subject: RE: FF-up on Immunization and family planning exp. that were missing in your accounts

9 am - no problem, morning coffee sounds great!
😊

Can you drop an email to the security me to get the pass?

David Gzirishvili

Managing Partner

Consulting Group Curatio Sarl

Geneva, Switzerland

From: EIGO, Natalja <[email-masked]>

Sent: Thursday, January 23, 2020 14:37

To: David Gzirishvili (CGC) <[email-masked]>

Cc: XU, Ke <[email-masked]>

Subject: RE: FF-up on Immunization and family planning exp. that were missing in your accounts

Ohh, great!

Do you think 9am will be too early?

Or if you want 10am will be also ok for us. Unfortunately I am busy after 11h00 and XuKe has plans short after that.

Best,

Natalja

From: David Gzirishvili (CGC) <[email-masked]>

Sent: Thursday, January 23, 2020 2:28 PM

To: EIGO, Natalja <[email-masked]>

Cc: XU, Ke <[email-masked]>; TOURE, Hapsatou <[email-masked]>

Subject: RE: FF-up on Immunization and family planning exp. that were missing in your accounts

Hello Natajla,

I cannot miss this opportunity to see you and Xu Ke.

I can come tomorrow and we can enjoy coffee together. Just decide when it is convenient for you.

Cheers,

David Gzirishvili

Managing Partner

Consulting Group Curatio Sarl

Geneva, Switzerland

From: EIGO, Natalja <[email-masked]>

Sent: Thursday, January 23, 2020 14:10

To: David Gzirishvili (CGC) <[email-masked]>

Cc: XU, Ke <[email-masked]>; TOURE, Hapsatou <[email-masked]>

Subject: RE: FF-up on Immunization and family planning exp. that were missing in your accounts

Dear David,

It is so pity that we did not know that you would be in HQ, we would be plan our time better.

Unfortunately me and XuKe have a TC at 15h00 today.  When do you leave?

Can we meet tomorrow?

Hope to see you,

Natalja

From: David Gzirishvili (CGC) <[email-masked]>

Sent: Thursday, January 23, 2020 11:15 AM

To: TOURE, Hapsatou <[email-masked]>

Cc: XU, Ke <[email-masked]>; EIGO, Natalja <[email-masked]>

Subject: RE: FF-up on Immunization and family planning exp. that were missing in your accounts

Dear Hapsa,

You have HC62 in TJK and KGZ reports.

I feel more confident in KGZ HC62 estimates.

PS. We can have coffee next time we are both in the office.

David Gzirishvili

Managing Partner

Consulting Group Curatio Sarl

Geneva, Switzerland

From: TOURE, Hapsatou <[email-masked]>

Sent: Thursday, January 23, 2020 11:12

To: David Gzirishvili (CGC) <[email-masked]>

Cc: XU, Ke <[email-masked]>; EIGO, Natalja <[email-masked]>

Subject: Re: FF-up on Immunization and family planning exp. that were missing in your accounts

Would have be a pleasure but not in the office today...

I wanted to discuss the fact that in the previous versions we were missing HC62 (Immunisation as a function) in both country ptstudy files. I can only have a look on the ones you just shared on Monday when I’ll
be back. But be assured we will revert to you in a concerted manner Natalja and I.

All the best +++

H.

Sent from my iPhone

On 23 Jan 2020, at 11:04, David Gzirishvili (CGC) <[email-masked]> wrote:

Dear Hapsa,

You see the latest version of pstudy files in the folders I shared.

We have changed many things in KGZ without affecting much GFATM or UNFPA funding except 2014 year.

As to TJK there should be no noticeable changes between Natalja’s version and my versions.

I am happy to answer your and Natalja’s questions at any time.
😊

What about having coffee today? I could be available after 15:00 (I attend a meeting in Building M).

Cheers,

David Gzirishvili

Managing Partner

Consulting Group Curatio Sarl

Geneva, Switzerland

From: TOURE, Hapsatou <[email-masked]>

Sent: Thursday, January 23, 2020 10:55

To: David Gzirishvili (CGC) <[email-masked]>

Cc: Baktygul Akkazieva (WHO) <[email-masked]>; XU, Ke <[email-masked]>; EIGO, Natalja <[email-masked]>

Subject: RE: FF-up on Immunization and family planning exp. that were missing in your accounts

Thank you David ! See my answers/comments below in your text.

Best, H.

From: David Gzirishvili (CGC) <[email-masked]>

Sent: Thursday, January 23, 2020 10:47

To: TOURE, Hapsatou <[email-masked]>

Cc: AKKAZIEVA, Baktygul <[email-masked]>; XU, Ke <[email-masked]>; EIGO, Natalja <[email-masked]>

Subject: RE: FF-up on Immunization and family planning exp. that were missing in your accounts

Dear Hapsa,

All information available to the countries (being it UNFPA supply, or GFATM support) were reflected in the latest version of PT studies. You can access KGZ ptstudy files

here, and TJK ptstudy files
here.

HT : Those are versions from Dec 30th  I can see ? Will sit with Natalja to make sure we are all on the same page. Then revert to you if anything
remains unclear (sorry…J). And when it comes to Armenia ?

Please be aware that UNFPA data may not be fully reflected. We noticed that some UNFPA support comes for GFATM projects, so we used either UNFPA or GFATM figures to avoid double-counting.

HT: yes that’s exactly what is recommended. Great. But how did you decide in the end to whom to attribute them (you said either to one or the other)?

PS. I wonder if GFATM can share more disaggregated (by intervention) data next time instead of giving module by module expenditures – it cannot be coded accurately, you know that.

HT: still discussing with them… will keep you posted.

All the best,

Thanks for the swift reply+++

H.

David Gzirishvili

Managing Partner

Consulting Group Curatio Sarl

Geneva, Switzerland

From: TOURE, Hapsatou <[email-masked]>

Sent: Thursday, January 23, 2020 10:27

To: David Gzirishvili (CGC) <[email-masked]>

Cc: Baktygul Akkazieva (WHO) <[email-masked]>; XU, Ke <[email-masked]>; EIGO, Natalja <[email-masked]>

Subject: FF-up on Immunization and family planning exp. that were missing in your accounts

Dear David,

Belated happy new year ! Hope all is fine on your end.

Following up on the below for immunization and family planning expenditures in Tajikistan and Kyrgyzstan. Did you get a chance to review your tables/keys
so that they are reflected in the accounts?

If not (yet), could you kindly share the underlying data as you suggested below? Sorry but we need to address this and the sooner the better – would be unfortunate
to miss the window of opportunity of Q1 to adjust the estimates in GHED.

I can give you a call early next week if that helps grasping what am saying.

Best,

H.

PS: Armenia should I directly reach out to Anastas ?

From: David Gzirishvili (CGC) <[email-masked]>

Sent: Tuesday, November 5, 2019 18:30

To: TOURE, Hapsatou <[email-masked]>

Cc: AKKAZIEVA, Baktygul <[email-masked]>; XU, Ke <[email-masked]>; ARANGUREN GARCIA, Maria Jackelin <[email-masked]>; EIGO, Natalja
<[email-masked]>

Subject: RE: HA EURO: Donor data

Dear Hapsa,

Thank you for sharing UNFPA estimates. I think we already reviewed 2017 procurements to avoid double-counting in Tajikistan and Kyrgyzstan where they supply commodities for the GF supported projects (thus, respective
expenditures already captured in pt study for both countries). However, we will double-check this issue.

I could not promise about Armenia, but we definitely will dive deeper into the issues related to DIS.2.3 and DIS.1.7 for KGZ and TJK:

·
DIS.2.3: Two main reasons come to my mind:

o
To my best knowledge, there family planning services in both countries are integrated into PHC or other levels of care, i.e. there are
no stand-alone facilities specialised in family planning. Therefore, expenditures you mentioned (direct such as labour, or indirect ones, such as space or utilities) cannot be tracked fully by health care facility or health care function (and
therefore, cannot be linked to HP and HC codes respectively, except few cases, at best). Therefore, I am not surprised you cannot see domestic financing of shared costs while some of family planning-related commodities (direct costs) financed from external
sources are easily trackable.

o
When it comes to general outpatient care, we do not have credible information on the consumption by disease and we use epidemiology (prevalence and incidence of diseases) as a proxy for the distribution of outpatient care expenditures by diseases.
I assume the routine medical statistics is not sensitive enough to DIS.2.3 related health conditions; thus, DIS.2.3 is underrepresented in epidemiological tables.

·
DIS.1.7: Immunisation services are fully integrated into PHC and maternity homes, so it means other than HC.6.2 that covers immunisation related supply chain and logistics, and surveillance, it is impossible to track shared costs (financed from
domestic sources). As to commodities, the situation differs by the countries:

o
TJK: UNICEF and JICA have been financing even commodities (so-called “traditional vaccines” usually covered from the state budget in most poor countries globally) instead of the Government while the TJK government spent most of its funds on co-financing
expensive Gavi supported vaccines (increasing allocation to 1.5 mln US$). I can recall the same strange pattern of financing in Laos… or/and Sudan.

o
KGZ: The Government has been paying for all traditional vaccines, and I hope this is properly reflected in the MOH budget breakdown. However, considering the fact that the total cost of BCG, or OPV or Dt (i.e. traditional vaccines) financed 100% from
the state budget is much less than the cost of PCV, HPV, Penta or MR), I don’t find it surprising that external funds prevail in DIS.1.7 financing.

o
Our team has been working on costing and financial sustainability of immunisation in TJK and KGZ for 15 years, and we can share with you as much as details as needed.

We plan to conduct another round of in-country consultations both in TJK and KGZ in December, so we will share your concerns with the country teams and respective the WHO COs and double-check the accuracy of
our estimations of immunisation related expenditures (by the financing schemes and its revenue sources). We are also very interested in dwelling on the possibilities of refining the SHA methodology for better tracking non-commodity immunisation expenditures
(to replace current financial sections of JRF with very questionable credibility).

All the best,

David Gzirishvili

Managing Partner

Consulting Group Curatio Sarl

Geneva, Switzerland

From: TOURE, Hapsatou <[email-masked]>

Sent: Tuesday, November 5, 2019 17:50

To: David Gzirishvili (CGC) <[email-masked]>

Cc: Baktygul Akkazieva (WHO) <[email-masked]>; XU, Ke <[email-masked]>; ARANGUREN GARCIA, Maria Jackelin <[email-masked]>; EIGO, Natalja
<[email-masked]>

Subject: RE: HA EURO: Donor data

Dear David,

Reviewing the disease estimates, for some countries we found very low values (extremely low ones) for DIS.2.3 from domestic public sources (FS.1 + FS.3).
Sometimes even a null value. Given that it is highly unlikely that government does not at least pay for salaries of the health personnel delivering services for family planning I am kindly asking that you please check the data for Armenia, Kyrgyzstan and Tajikistan.
I have done the detailed review for these specifically, just raising it as a potential issue. While we’re on this this could you also do the same for immunization expenditures (HC.6.2 x domestic public sources)? The rationale being the same.

Then coming to EXT (FS.2 + FS.7) for family planning, kindly see attached a dataset downloaded from UNFPA website. These are procurement data handled via
UNFPA’s platform – please note that the buyer can be the government, it is not systematically a foreign entity.

Please do me a favor and double check the estimates given these 2 comments (there should be some govt spending on HR as a minimum, and run a comparison of
this excel to your data).

Best,

H.

Ps: immunization I do not have a detailed dataset from Gavi despite asking several times, so we have to live with the disbursement file downloadable from
their website.

From: David Gzirishvili (CGC) <[email-masked]>

Sent: Wednesday, October 23, 2019 14:38

To: TOURE, Hapsatou <[email-masked]>

Cc: AKKAZIEVA, Baktygul <[email-masked]>; XU, Ke <[email-masked]>; ARANGUREN GARCIA, Maria Jackelin <[email-masked]>

Subject: RE: HA EURO: Donor data

Dear Hapsa,

Thank you so much!
😊

David Gzirishvili

Managing Partner

Consulting Group Curatio Sarl

Geneva, Switzerland

From: TOURE, Hapsatou <[email-masked]>

Sent: Wednesday, October 23, 2019 16:23

To: David Gzirishvili (CGC) <[email-masked]>

Cc: Baktygul Akkazieva (WHO) <[email-masked]>; XU, Ke <[email-masked]>; ARANGUREN GARCIA, Maria Jackelin <[email-masked]>

Subject: RE: HA EURO: Donor data

Hi David

Attached data from the Global Fund. I have not got a chance to review the data, please let me know if you find anything “funny”.

Best,

H.

From: TOURE, Hapsatou

Sent: Friday, October 18, 2019 05:58

To: David Gzirishvili (CGC) <[email-masked]>

Cc: AKKAZIEVA, Baktygul <[email-masked]>; XU, Ke <[email-masked]>; ARANGUREN GARCIA, Maria Jackelin <[email-masked]>

Subject: Re: HA EURO: Donor data

Hi David

Responding from Dubai airport where am connecting back to Geneva.

Global fund data am hearing you. Let me revert by Monday. May have a solution.

Best,

H

Sent from my iPhone

On 18 Oct 2019, at 01:10, David Gzirishvili (CGC) <[email-masked]> wrote:

Dear Hapsa,

Do you have the Global Fund data with 2017 expenditures?

We will wait for 2018 data, but GFATM expenditures in 2017 are critical for us.

Can you please help?

David Gzirishvili

Managing Partner

Consulting Group Curatio Sarl

Geneva, Switzerland

From: TOURE, Hapsatou <[email-masked]>

Sent: Thursday, August 22, 2019 14:05

To: David Gzirishvili (CGC) <[email-masked]>

Cc: Baktygul Akkazieva (WHO) <[email-masked]>; XU, Ke <[email-masked]>; ARANGUREN GARCIA, Maria Jackelin <[email-masked]>

Subject: RE: HA EURO: Donor data

Dear David

I have not forgotten you. The only thing is I have yet to receive an updated file from the Global Fund. They have not shared the data with Year 2018 elements
with us.

I sent a reminder, let’s see how quick we can get it from now.

For the others I will compile what I have and share with you.

Best,

H.

From: David Gzirishvili (CGC) <[email-masked]>

Sent: Wednesday, August 21, 2019 6:51 PM

To: TOURE, Hapsatou <[email-masked]>

Cc: AKKAZIEVA, Baktygul <[email-masked]>; XU, Ke <[email-masked]>

Subject: FW: HA EURO: Donor data

Dear Hapsa,

Just checking whether you got my previous email.

Can you please help us with GFATM expenditures?

I also discovered that Gavi actual disbursement data did not cover the entire year of 2018.  Should we use approved amounts then as a proxy of disbursements (that still
is not equivalent to the amount of final consumption…)?

Can you please advise?

All the best,

David Gzirishvili

Managing Partner

Consulting Group Curatio Sarl

From: David Gzirishvili (CGC)

Sent: Tuesday, July 30, 2019 09:19

To: Hapsatou Toure (WHO) <[email-masked]>

Cc: Baktygul Akkazieva (WHO BO)

Subject: HA EURO: Donor data

Dear Hapsa,

You kindly provided donor data on country support last year (e.g. EUR 2010-2016 GFATM Expenditure_As of 2018.xlsx).

Would it be possible to get similar data on GFATM and UNFPA country support (or any other donor)? I know where to get Gavi figures on the web.

All the best,

David Gzirishvili

Managing Partner

Consulting Group Curatio Sarl

Geneva, Switzerland

Mobile: +44 7937 978 488